In line with our results, mRNAs such as Bcl2 (Iwata et al., 2010), Bcl-W (Minami et al., 2000), Bcl-XL (Wiessner et al., 1999) and Casp3 (Gorup et al., 2015) and some miRNAs, such as miR-143-3p (Tiedt et al., 2017), miR-26b-3p (Yuan et al., 2016) and miR-339-5p (Dhiraj et al., 2013), that were previously reported to be up- or down-regulated in AIS patients were also found in this study. Here, BCL2L1 is linked to androgen insensitivity syndrome.